Madlen Jentzsch

35PUBLICATIONS
100CO-AUTHORS
HaematologyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)Synchrotrons and accelerators not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|Jul 15, 2026
Relapse risk after FLAMSA RIC based allogeneic hematopoietic stem cell transplantation in heavily pretreated AML patients.

|Jun 03, 2026
Clonal Hematopoiesis does not influence manufacturing of Chimeric Antigen Receptor (CAR) T-Cells.

|Apr 06, 2026
Body composition predicts poor outcomes and reveals immunometabolic dysfunction via single-cell profiling in anti-BCMA CAR T-treated myeloma.

Thomas C Wiemers, Michael Rade, Nora Grieb

|Feb 17, 2026
MyCARdiac score: integrating cardiac imaging and biomarkers to predict outcomes in RRMM patients receiving cilta-cel.

Thomas C Wiemers, Nora Grieb, Maximilian Ferle

|Dec 02, 2025
The sequence of 12 Gy total body irradiation and cyclophosphamide does not impact outcomes in AML patients receiving myeloablative allogeneic stem cell transplantation.

Georg-Nikolaus Franke, Jule Ussmann, Donata Backhaus

|Jul 21, 2025
Gemtuzumab ozogamicin in first-line treatment of CBF-AML: insights from a retrospective multi-center analysis.

Julian Ronnacker, Philippe J Muller, Jan-Henrik Mikesch

Pageof 6

Frequent Collaborators

22 joint publications

Sebastian Schwind

20 joint publications

Vladan Vucinic

14 joint publications

Klaus Metzeler

14 joint publications

Uwe Platzbecker